TY  - JOUR
A1  - Notz, Quirin
A1  - Herrmann, Johannes
A1  - Schlesinger, Tobias
A1  - Helmer, Philipp
A1  - Sudowe, Stephan
A1  - Sun, Qian
A1  - Hackler, Julian
A1  - Roeder, Daniel
A1  - Lotz, Christopher
A1  - Meybohm, Patrick
A1  - Kranke, Peter
A1  - Schomburg, Lutz
A1  - Stoppe, Christian
T1  - Clinical Significance of Micronutrient Supplementation in Critically Ill COVID-19 Patients with Severe ARDS
JF  - Nutrients
N2  - The interplay between inflammation and oxidative stress is a vicious circle, potentially resulting in organ damage. Essential micronutrients such as selenium (Se) and zinc (Zn) support anti-oxidative defense systems and are commonly depleted in severe disease. This single-center retrospective study investigated micronutrient levels under Se and Zn supplementation in critically ill patients with COVID-19 induced acute respiratory distress syndrome (ARDS) and explored potential relationships with immunological and clinical parameters. According to intensive care unit (ICU) standard operating procedures, patients received 1.0 mg of intravenous Se daily on top of artificial nutrition, which contained various amounts of Se and Zn. Micronutrients, inflammatory cytokines, lymphocyte subsets and clinical data were extracted from the patient data management system on admission and after 10 to 14 days of treatment. Forty-six patients were screened for eligibility and 22 patients were included in the study. Twenty-one patients (95%) suffered from severe ARDS and 14 patients (64%) survived to ICU discharge. On admission, the majority of patients had low Se status biomarkers and Zn levels, along with elevated inflammatory parameters. Se supplementation significantly elevated Se (p = 0.027) and selenoprotein P levels (SELENOP; p = 0.016) to normal range. Accordingly, glutathione peroxidase 3 (GPx3) activity increased over time (p = 0.021). Se biomarkers, most notably SELENOP, were inversely correlated with CRP (r\(_s\) = −0.495), PCT (r\(_s\) = −0.413), IL-6 (r\(_s\) = −0.429), IL-1β (r\(_s\) = −0.440) and IL-10 (r\(_s\) = −0.461). Positive associations were found for CD8\(^+\) T cells (r(_s\) = 0.636), NK cells (r\(_s\) = 0.772), total IgG (r\(_s\) = 0.493) and PaO\(_2\)/FiO\(_2\) ratios (r\(_s\) = 0.504). In addition, survivors tended to have higher Se levels after 10 to 14 days compared to non-survivors (p = 0.075). Sufficient Se and Zn levels may potentially be of clinical significance for an adequate immune response in critically ill patients with severe COVID-19 ARDS.
KW  - acute respiratory distress syndrome
KW  - selen
KW  - zinc
KW  - critical care
KW  - oxidative stress
KW  - nutrient supplementation
Y1  - 2021
U6  - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-241112
SN  - 2072-6643
VL  - 13
IS  - 6
ER  - 
TY  - THES
A1  - Nhan, Pham Phuoc
T1  - Accumulation and biological activity of oxidized lipids in Anabaena PCC 7120
T1  - Akkumulation und biologische Aktivität von oxidierten Fettsäuren in Anabaena PCC 7120
N2  - Oxylipine sind wichtige biologisch aktive Verbindungen, die entscheidende Rollen in der Abwehr, dem Wachstum, der Entwicklung und der Reproduktion von Pflanzen und Tieren spielen. Oxylipine können entweder über enzymatische Wege oder eine Radikal-katalysierte Reaktion gebildet werden. Enzymatische und nicht-enzymatische Oxidationsprodukte der Arachidonsäure (C20:4) in Tieren sind Prostaglandine und Isoprostane. In Pflanzen werden ausgehend von der -Linolensäure (C18:3) über einen enzymatischen Weg OPDA und Jasmonsäure und durch Radikal-katalysierte Reaktion Phytoprostane gebildet. Die Membranen von Cyanobakterien enthalten, ähnlich denen von Pflanzen, einen großen Anteil an mehrfach ungesättigten Fettsäuren, ca. 25% der gesamten Fettsäuren. Biosynthese und Funktionen der Oxylipine wurden an zwei Modell-Cyanobakterien, Anabaena PCC 7120 und Synechocystis PCC 6803 untersucht: 1. Das fadenförmige Cyanobakterium Anabaena PCC 7120 kann Phytoprostane Typ I und II sowie Hydroxyfettsäuren ähnlich wie Pflanzen produzieren aber die enzymatische Ausstattung zur Bildung von Jasmonaten (12-oxo-Phytodiensäure und Jasmonsäure) und Prostaglandinen ist nicht vorhanden. Die erhaltenen Daten stellen den ersten Nachweis für das Vorkommen von Phytoprostanen in Cyanobakterien bzw. bei Prokaryonten dar. 2. Durch GC-MS Analyse wurden E1- and F1-Phytoprostane in Anabaena PCC 7120 in freier und veresterter Form detektiert. Die Spiegel sind vergleichbar mit denen in Pflanzen und lagen im Bereich von ng/g TG. PPF1 ließen sich nicht in einwöchigen Kulturen nachweisen, die Spiegel in sechswöchigen Kulturen lagen bei 142 ng/l. Die Spiegel von PPE1 waren hingegen in ein- und sechswöchigen Kulturen ähnlich und lagen bei ca. 20 ng/g TG. Die Mengen an freien PPE1 in den Zellen waren mit 80.5  23.6 etwa viermal höher als die von PPF1 mit 24.1  10.9 ng/g TG. Allerdings gab es keine signifikanten Unterschiede in den Spiegeln an gesamten PPF1 und PPE1 in den Zellen, sie lagen im Bereich von 150 bis zu ca. 200 ng/g TG. 3. Die Akkumulation von Phytoprostanen in Anabaena ist induzierbar. Nach der Kombination von oxidativem Stress (200 µM H2O2 oder 10 µM CuSO4) und hoher Lichtintensität (330 µE.m-2.s-1) für 8 h stiegen die Spiegel an gesamten PPE1 und PPF1 um den Faktor 2 bis 4 an. Interessanterweise führte im Gegensatz zu höheren Pflanzen die Applikation von oxidativem Stress oder hoher Lichtintensität alleine nicht zur Induktion der Phytoprostanakkumulation in diesen Cyanobakterien. 4. Eine Vorbehandlung von Anabaena Zellen mit exogenen Phytoprostanen führte zu einer erhöhten Toleranz gegenüber oxidativem Stress. Alle Phytoprostane außer PPE1 zeigten einen Schutzeffekt. Eine Mischung von PPA1 Typ I und II ergab den höchsten Schutzeffekt. Eine Vorinkubation von Anabena Zellen mit 100 µM PPA1–type I/II für 16 h schützte 84.2% beziehungsweise 77.5% der Zellen vor einer anschießenden lethalen Applikation von 1 mM H2O2 beziehungsweise 50 µM CuSO4 für 5 h. Ohne eine Oxylipin-Vorinkubation starben etwa 98% der Zellen. Überraschenderweise ergab auch die Vorbehandlung mit anderen, enzymatisch gebildeten Oxylipinen aus Tieren und Pflanzen einen Schutzeffekt, der allerdings nur 10 bis 30% betrug. Dagegen schützte eine Phytoprostan-Vorbehandlung nicht Pseudomonas syringae und Escherichia coli gegen toxische Mengen von Wasserstoffperoxid. Allerdings fehlen in den Membranen dieser Bakterien mehrfach ungesättigte Fettsäuren und deshalb endogen oxydierte Lipide. 5. Eine exogene Applikation von 100 µM PPF1 oder 1,5 mM H2O2 führte in Anabaena nicht zu einer Induktion der Expression des isiA Gens. Oxylipin-Behandlungen zeigten auch keine Wirkung auf Shinorin- und Tocopherol-Spiegel in Anabaena. Die Applikation von 100 µM PPF1 für 6 h führte aber zu Änderungen im Proteinmuster in Anabaena. Der größte Teil der differentiellen Proteine wurde durch PPF1 herunterreguliert. Bei vielen dieser Proteine handelt es sich um photosynthetische Proteine. Da ein oxidativer Stress nur in der Kombination mit hoher Lichtintensität die Lipidperoxidation erhöht, könnte die negative Regulation der Photosynthese nach Erkennung von oxydierten Lipiden (Phytoprostanen) eine Überlebens-Strategie sein um Schäden durch peroxidierte Lipide zu vermeiden. 6. Tote Pflanzen könnten eine hauptsächliche Quelle der exogenen Phytoprostane in der natürlichen Umgebung von Anabaena sein. Trockenes Heu gibt PPE1 und PPF1 (11 µg/g TG) an die wässerige Umgebung ab. Anabaena ist ein typisches Cyanobakterium in Reisfeldern. Nach der Ernte bleiben meist die nicht genutzten Teile der Reispflanzen auf dem Feld. Diese könnten Phytoprostane abgeben, die wiederum einen Einfluß auf die Cyanobakterien im Reis-Ökosystem haben könnten. 7. Eine neue Kategorie von Oxylipinen, die Phytoprostane Typ III und IV, wurden in vitro identifiziert und quantifiziert. Die beiden Haupt-Phytoprostane, PPE1 und PPF1 (Typ III und IV), können durch die Autoxidation der -Linolensäure oder des Borretschsamenöls (enthält 25% der -Linolensäure) gewonnen werden. Nach 12 Tagen Autoxidation und anschließender Hydrolyse wurden aus 1 g Borretschsamenöl 112,71 ± 1,93 µg PPF1 und 3,80 ± 0,14 mg PPE1 isoliert. PPB1 und PPA1 (Typ III und IV) wurden durch Isomerisierung und Dehydratisierung von PPE1 hergestellt. Die Ausbeute von PPB1 lag bei 1,71 ± 0,04 mg/g Öl (Typ III) und 2,09 ± 0,12 mg/g Öl (Typ IV), die von PPA1 lag bei 8,38 ± 0,35 µg/g und 10,18 ± 0,30 µg/g Öl. 8. Es wurde eine schnelle HPLC-MS/MS Methode für die Analytik der Phytoprostane und Phytohormone entwickelt. Diese Methode wurde für die Quantifizierung von freien und veresterten E1- and F1-Phytoprostane Typ III und IV in Synechocystis PCC 6803 angewendet. Die Phytoprostane Typ III und IV sind in vivo in freier und veresterter Form vorhanden. Die Spiegel der gesamten PPE1 Typ III und IV in Synechocystis sind mindestens doppelt so hoch wie die von PPF1. Im Gegensatz zu Anabaena, waren PPE1 und PPF1 in ein- und sechswöchigen Kulturen von Synechocystis detektierbar. Die Spiegel an freien PPF1 im Medium (231,8 ± 36,2 ng/l) und in den Zellen (164,9 ± 15,2 ng/g TG) waren niedriger als die von PPE1 (1003,3 ± 365,2 ng/l und 2331,0 ± 87,7 ng/g TG).
N2  - Oxylipins are important biological active compounds that play essential roles in defense, growth, development, and reproduction of plants and animals. Oxylipins are formed either by enzymatic pathways or radical catalyzed reaction from polyunsaturated fatty acids. Products of oxidation of arachidonic acid (C20:4) in animals by enzymatic and non-enzymatic pathways are prostaglandins and isoprostanes, respectively. In plants, radical catalyzed reaction of -linolenic acid (C18:3) forms phytoprostanes and enzymatic oxidation of this fatty acid produces OPDA and jasmonic acid. Like plants, cyanobacterial membranes contain a high ratio of polyunsaturated fatty acid, about 25% of total fatty acids. Oxylipin biosynthesis and function was studied in two model cyanobacteria, Anabaena PCC 7120 and Synechocystis PCC 6803, for the first time: 1. The filamentous cyanobaterium Anabaena PCC 7120 can naturally produce phytoprostanes type I and II as well as hydroxy fatty acids like in plants but lacks the enzymatic capacity to form jasmonates (12-oxo-phytodienoic acid and jasmonic acid) and prostaglandins. Data obtained provide the first evidence for the occurence of phytoprostanes in cyanobacteria as well as in the baterial kingdom. 2. By GC-MS analysis, the E1- and F1-phytoprostanes in Anabaena PCC 7120 were detected both in free and esterified form. Their levels are comparable with those in plants, in the range of ng/g DW. In one week old cultures, there was no evidence of PPF1 in the medium but its level accumulated up to 142 ng/l in six weeks old cultures. In contrast, PPE1 was stable over time, about 20 ng/g DW. Free cellular PPE1 was found about 4 times higher than that of PPF1, 80.5  23.6 and 24.1  10.9 ng/g DW, respectively. However, there was no significant difference in the total cellular levels of PPF1 and PPE1, ranging from 150 to about 200 ng/g DW. 3. Phytoprostanes are inducible in Anabaena. In the combination of oxidative stress (200 µM H2O2 or 10 µM CuSO4) with high light intensity (330 µE.m-2.s-1) for 8 h, levels of total cellular PPE1 and PPF1 were increased about 2 to 4 times. Interestingly, unlike in higher plants, application of oxidative stress or high light intensity alone showed no phytoprostaneous induction in this cyanobacterium. 4. When Anabaena cells were treated with phytoprostanes, Anabaena cells became remarkably resistant against subsequently applied – otherwise lethal – oxidative stress. All phytoprostanes displayed a high protective effect except for PPE1. The highest protection level was contributed by a mixture of PPA1 type I and II. After preincubation of Anabena cells with 100 µM PPA1–type I/II for 16 h followed by application of 1 mM H2O2 or 50 µM CuSO4 for 5 h, A1-phytoprostane pre-treatment protected 84.2% and 77.5% of the cells from cell death, respectively. Without oxylipins pre-treatment, about 98% of the cells were dead. Surprisingly, preincubation of Anabaena with other oxylipins derived from enzymatic pathway in plants and animals showed also an effect, however, the protection effect was low and ranged from 10 to 30%. In contrast, phytoprostanes did not protect Pseudomonas syringae and Escherichia coli from the toxicity of hydrogen peroxide. However, these bacteria do not synthesize polyunsaturated fatty acids and are therefore devoid of and not exposed to endogenously formed oxidized lipids. 5. Exogenous application of 100 µM PPF1 or 1.5 mM H2O2 for 90 min did not activate the expression of isiA in Anabaena. Oxylipins also displayed no effect on shinorine and tocopherol levels in Anabaena. However, application of 100 µM PPF1 for 6 h altered the protein expression in Anabaena. Most PPF1-modulated proteins are down-regulated and related to photosynthesis. Since oxidative stress only in combination with high light intensity increased lipid peroxidation, down-regulation of photosynthesis after recognition of oxidised lipids (phytoprostanes) may be a survival strategy of Anabaena to avoid damage by peroxidized lipids. 6. Dead plants may be the main source of (exogenous) phytoprostanes in the natural environment of Anabaena. Dry hay releases PPE1 and PPF1 (11 µg/g DW) into an aqueous environment. Anabaena is the typical cyanobacterium in paddy rice fields. After harvesting, most of uneconomical parts of rice plants are abundant on the field, which may release phytoprostanes that in turn might have an impact on cyanobacteria in the rice ecosystems. However, field research is needed to clarify this suspection. 7. A new class of oxylipins, phytoprostanes type III and IV, was identified and quantified in vitro. The two main phytoprostanes, PPE1 and PPF1 (type III and IV), can be obtained by autoxidation of -linolenic acid or Borage oil (containing 25% esterified -linolenic acid). After 12 days of autoxidation and subsequent hydrolysis, 1 g of Borage oil yielded 112.71 ± 1.93 µg of PPF1 and 3.80 ± 0.14 mg of PPE1. PPB1 and PPA1 (type III and IV) were prepared by isomerization and dehydration of PPE1 (type III and IV). The overall yield of PPB1 was 1.71 ± 0.04 mg/g oil (type III) and 2.09 ± 0.12 mg/g oil (type IV). Those of PPA1 were 8.38 ± 0.35 µg/g and 10.18 ± 0.30 µg/oil, respectively. 8. A rapid HPLC-MS/MS method for phytoprostane and phytohormone analysis has been developed. This method was applied to quantify free and esterified E1- and F1-phytoprostanes type III and IV in Synechocystis PCC 6803. The in vivo phytoprostanes type III and IV are present both in free and esterified form. The total cellular level of PPE1 type III and IV in Synechocystis is at least 2 times higher than that of PPF1. Unlike Anabaena, PPE1 and PPF1 were detectable in the medium of one week old Synechocystis cultures. Free levels of PPF1 in the medium (231.8 ± 36.2 ng/l) and in the cells (164.9 ± 15.2 ng/g DW) are lower than those of PPE1 (1003.3 ± 365.2 ng/l and 2331.0 ± 87.7 ng/g DW).
KW  - Oxidativer Stress
KW  - oxidative stress
KW  - phytoprostane
KW  - oxidized lipids
Y1  - 2007
U6  - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-24347
ER  - 
TY  - JOUR
A1  - Müller, Thomas
A1  - Mueller, Bernhard Klaus
A1  - Riederer, Peter
T1  - Perspective: Treatment for disease modification in chronic neurodegeneration
JF  - Cells
N2  - Symptomatic treatments are available for Parkinson's disease and Alzheimer's disease. An unmet need is cure or disease modification. This review discusses possible reasons for negative clinical study outcomes on disease modification following promising positive findings from experimental research. It scrutinizes current research paradigms for disease modification with antibodies against pathological protein enrichment, such as α-synuclein, amyloid or tau, based on post mortem findings. Instead a more uniform regenerative and reparative therapeutic approach for chronic neurodegenerative disease entities is proposed with stimulation of an endogenously existing repair system, which acts independent of specific disease mechanisms. The repulsive guidance molecule A pathway is involved in the regulation of peripheral and central neuronal restoration. Therapeutic antagonism of repulsive guidance molecule A reverses neurodegeneration according to experimental outcomes in numerous disease models in rodents and monkeys. Antibodies against repulsive guidance molecule A exist. First clinical studies in neurological conditions with an acute onset are under way. Future clinical trials with these antibodies should initially focus on well characterized uniform cohorts of patients. The efficiency of repulsive guidance molecule A antagonism and associated stimulation of neurogenesis should be demonstrated with objective assessment tools to counteract dilution of therapeutic effects by subjectivity and heterogeneity of chronic disease entities. Such a research concept will hopefully enhance clinical test strategies and improve the future therapeutic armamentarium for chronic neurodegeneration.
KW  - neurodegeneration
KW  - repulsive guidance molecule A
KW  - neuroprotection
KW  - repair
KW  - oxidative stress
KW  - apoptosis
KW  - neurogenesis
Y1  - 2021
U6  - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-236644
SN  - 2073-4409
VL  - 10
IS  - 4
ER  - 
TY  - JOUR
A1  - Magliocca, Giorgia
A1  - Mone, Pasquale
A1  - Di Iorio, Biagio Raffaele
A1  - Heidland, August
A1  - Marzocco, Stefania
T1  - Short-chain fatty acids in Chronic Kidney Disease: focus on inflammation and oxidative stress regulation
JF  - International Journal of Molecular Sciences
N2  - Chronic Kidney Disease (CKD) is a debilitating disease associated with several secondary complications that increase comorbidity and mortality. In patients with CKD, there is a significant qualitative and quantitative alteration in the gut microbiota, which, consequently, also leads to reduced production of beneficial bacterial metabolites, such as short-chain fatty acids. Evidence supports the beneficial effects of short-chain fatty acids in modulating inflammation and oxidative stress, which are implicated in CKD pathogenesis and progression. Therefore, this review will provide an overview of the current knowledge, based on pre-clinical and clinical evidence, on the effect of SCFAs on CKD-associated inflammation and oxidative stress.
KW  - chronic kidney disease
KW  - short-chain fatty acids
KW  - oxidative stress
KW  - inflammation
KW  - uremic toxins
Y1  - 2022
U6  - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-284587
SN  - 1422-0067
VL  - 23
IS  - 10
ER  - 
TY  - JOUR
A1  - Macdougall, Iain C.
A1  - Bircher, Andreas J.
A1  - Eckhardt, Kai-Uwe
A1  - Obrador, Gregorio T.
A1  - Pollock, Carol A.
A1  - Stenvinkel, Peter
A1  - Swinkels, Dorine W.
A1  - Wanner, Christoph
A1  - Weiss, Günter
A1  - Chertow, Glenn M.
T1  - Iron management in chronic kidney disease: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference
JF  - Kidney International
N2  - Before the introduction of erythropoiesis-stimulating agents (ESAs) in 1989, repeated transfusions given to patients with end-stage renal disease caused iron overload, and the need for supplemental iron was rare. However, with the widespread introduction of ESAs, it was recognized that supplemental iron was necessary to optimize hemoglobin response and allow reduction of the ESA dose for economic reasons and recent concerns about ESA safety. Iron supplementation was also found to be more efficacious via intravenous compared to oral administration, and the use of intravenous iron has escalated in recent years. The safety of various iron compounds has been of theoretical concern due to their potential to induce iron overload, oxidative stress, hypersensitivity reactions, and a permissive environment for infectious processes. Therefore, an expert group was convened to assess the benefits and risks of parenteral iron, and to provide strategies for its optimal use while mitigating the risk for acute reactions and other adverse effects.
KW  - chronic kidney disease
KW  - hypersensitivity
KW  - infections
KW  - iron
KW  - overload
KW  - oxidative stress
Y1  - 2016
U6  - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-191467
VL  - 89
IS  - 1
ER  - 
TY  - JOUR
A1  - Leonhardt, Ines
A1  - Spielberg, Steffi
A1  - Weber, Michael
A1  - Albrecht-Eckardt, Daniela
A1  - Bläss, Markus
A1  - Claus, Ralf
A1  - Barz, Dagmar
A1  - Scherlach, Kirstin
A1  - Hertweck, Christian
A1  - Löffler, Jürgen
A1  - Hünniger, Kerstin
A1  - Kurzai, Oliver
T1  - The fungal quorum-sensing molecule farnesol activates innate immune cells but suppresses cellular adaptive immunity
JF  - mBio
N2  - Farnesol, produced by the polymorphic fungus Candida albicans, is the first quorum-sensing molecule discovered in eukaryotes. Its main function is control of C. albicans filamentation, a process closely linked to pathogenesis. In this study, we analyzed the effects of farnesol on innate immune cells known to be important for fungal clearance and protective immunity. Farnesol enhanced the expression of activation markers on monocytes (CD86 and HLA-DR) and neutrophils (CD66b and CD11b) and promoted oxidative burst and the release of proinflammatory cytokines (tumor necrosis factor alpha [TNF-\(\alpha\)] and macrophage inflammatory protein 1 alpha [MIP-1 \(\alpha\)]). However, this activation did not result in enhanced fungal uptake or killing. Furthermore, the differentiation of monocytes to immature dendritic cells (iDC) was significantly affected by farnesol. Several markers important for maturation and antigen presentation like CD1a, CD83, CD86, and CD80 were significantly reduced in the presence of farnesol. Furthermore, farnesol modulated migrational behavior and cytokine release and impaired the ability of DC to induce T cell proliferation. Of major importance was the absence of interleukin 12 (IL-12) induction in iDC generated in the presence of farnesol. Transcriptome analyses revealed a farnesol-induced shift in effector molecule expression and a down-regulation of the granulocyte-macrophage colony-stimulating factor (GM-CSF) receptor during monocytes to iDC differentiation. Taken together, our data unveil the ability of farnesol to act as a virulence factor of C. albicans by influencing innate immune cells to promote inflammation and mitigating the Th1 response, which is essential for fungal clearance.
KW  - human dendritic cells
KW  - Pseudomonas aeruginosa
KW  - induced apoptosis
KW  - cytokine production
KW  - biofilm formation
KW  - Candida albicans
KW  - mouse model
KW  - systemic candidiasis
KW  - oxidative stress
KW  - carcinoma cells
Y1  - 2015
U6  - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-143756
VL  - 6
IS  - 2
ER  - 
TY  - JOUR
A1  - Klotz, Barbara
A1  - Mentrup, Birgit
A1  - Regensburger, Martina
A1  - Zeck, Sabine
A1  - Schneidereit, Jutta
A1  - Schupp, Nicole
A1  - Linden, Christian
A1  - Merz, Cornelia
A1  - Ebert, Regina
A1  - Jakob, Franz
T1  - 1,25-Dihydroxyvitamin D3 Treatment Delays Cellular Aging in Human Mesenchymal Stem Cells while Maintaining Their Multipotent Capacity
JF  - PLoS ONE
N2  - 1,25-dihydroxyvitamin D3 (1,25D3) was reported to induce premature organismal aging in fibroblast growth factor-23 (Fgf23) and klotho deficient mice, which is of main interest as 1,25D3 supplementation of its precursor cholecalciferol is used in basic osteoporosis treatment. We wanted to know if 1,25D3 is able to modulate aging processes on a cellular level in human mesenchymal stem cells (hMSC). Effects of 100 nM 1,25D3 on hMSC were analyzed by cell proliferation and apoptosis assay, beta-galactosidase staining, VDR and surface marker immunocytochemistry, RT-PCR of 1,25D3-responsive, quiescence-and replicative senescence-associated genes. 1,25D3 treatment significantly inhibited hMSC proliferation and apoptosis after 72 h and delayed the development of replicative senescence in long-term cultures according to beta-galactosidase staining and P16 expression. Cell morphology changed from a fibroblast like appearance to broad and rounded shapes. Long term treatment did not induce lineage commitment in terms of osteogenic pathways but maintained their clonogenic capacity, their surface marker characteristics (expression of CD73, CD90, CD105) and their multipotency to develop towards the chondrogenic, adipogenic and osteogenic pathways. In conclusion, 1,25D3 delays replicative senescence in primary hMSC while the pro-aging effects seen in mouse models might mainly be due to elevated systemic phosphate levels, which propagate organismal aging.
KW  - perspectives
KW  - bone marrow
KW  - mutant mice
KW  - oxidative stress
KW  - transcription factors
KW  - vitamin-D-receptor
KW  - differentiation
KW  - tissue
KW  - 2',7'-dichlorofluorescin
KW  - homeostasis
Y1  - 2012
U6  - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-133392
VL  - 7
IS  - 1
ER  - 
TY  - JOUR
A1  - Kleikers, Pamela W. M.
A1  - Hooijmans, Carlijn
A1  - Göb, Eva
A1  - Langhauser, Friederike
A1  - Rewell, Sarah S. J.
A1  - Radermacher, Kim
A1  - Ritskes-Hoitinga, Merel
A1  - Howells, David W.
A1  - Kleinschnitz, Christoph
A1  - Schmidt, Harald H. H. W.
T1  - A combined pre-clinical meta-analysis and randomized confirmatory trial approach to improve data validity for therapeutic target validation
JF  - Scientific Reports
N2  - Biomedical research suffers from a dramatically poor translational success. For example, in ischemic stroke, a condition with a high medical need, over a thousand experimental drug targets were unsuccessful. Here, we adopt methods from clinical research for a late-stage pre-clinical meta-analysis (MA) and randomized confirmatory trial (pRCT) approach. A profound body of literature suggests NOX\(_{2}\) to be a major therapeutic target in stroke. Systematic review and MA of all available NOX\(_{2}\)\(^{-/y}\) studies revealed a positive publication bias and lack of statistical power to detect a relevant reduction in infarct size. A fully powered multi-center pRCT rejects NOX\(_{2}\) as a target to improve neurofunctional outcomes or achieve a translationally relevant infarct size reduction. Thus stringent statistical thresholds, reporting negative data and a MA-pRCT approach can ensure biomedical data validity and overcome risks of bias.
KW  - focal cerebral ischemia
KW  - darbepoetin alpha
KW  - mice
KW  - translational stroke research
KW  - colony-stimulating factor
KW  - NADPH oxidase inhibitors
KW  - chronic kidney disease
KW  - diabetes mellitus
KW  - oxidative stress
KW  - search filter
Y1  - 2015
U6  - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-151401
VL  - 5
IS  - 13428
ER  - 
TY  - JOUR
A1  - Kim, Jae Ho
A1  - Franck, Julien
A1  - Kang, Taewook
A1  - Heinsen, Helmut
A1  - Ravid, Rivka
A1  - Ferrer, Isidro
A1  - Cheon, Mi Hee
A1  - Lee, Joo-Yong
A1  - Yoo, Jong Shin
A1  - Steinbusch, Harry W.
A1  - Salzet, Michel
A1  - Fournier, Isabelle
A1  - Park, Young Mok
T1  - Proteome-wide characterization of signalling interactions in the hippocampal CA4/DG subfield of patients with Alzheimer's disease
JF  - Scientific Reports
N2  - Alzheimer's disease (AD) is the most common form of dementia; however, mechanisms and biomarkers remain unclear. Here, we examined hippocampal CA4 and dentate gyrus subfields, which are less studied in the context of AD pathology, in post-mortem AD and control tissue to identify possible biomarkers. We performed mass spectrometry-based proteomic analysis combined with label-free quantification for identification of differentially expressed proteins. We identified 4,328 proteins, of which 113 showed more than 2-fold higher or lower expression in AD hippocampi than in control tissues. Five proteins were identified as putative AD biomarkers (MDH2, PCLO, TRRAP, YWHAZ, and MUC19 isoform 5) and were cross-validated by immunoblotting, selected reaction monitoring, and MALDI imaging. We also used a bioinformatics approach to examine upstream signalling interactions of the 113 regulated proteins. Five upstream signalling (IGF1, BDNF, ZAP70, MYC, and cyclosporin A) factors showed novel interactions in AD hippocampi. Taken together, these results demonstrate a novel platform that may provide new strategies for the early detection of AD and thus its diagnosis.
KW  - imaging mass spectrometry
KW  - neuron navigator 3
KW  - dentate gyrus
KW  - growth factor
KW  - mouse model
KW  - neurotrophic factor
KW  - entorhinal cortex
KW  - factor expression
KW  - oxidative stress
KW  - memory deficits
Y1  - 2015
U6  - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-151727
VL  - 5
IS  - 11138
ER  - 
TY  - JOUR
A1  - Karnati, Srikanth
A1  - Seimetz, Michael
A1  - Kleefeldt, Florian
A1  - Sonawane, Avinash
A1  - Madhusudhan, Thati
A1  - Bachhuka, Akash
A1  - Kosanovic, Djuro
A1  - Weissmann, Norbert
A1  - Krüger, Karsten
A1  - Ergün, Süleyman
T1  - Chronic Obstructive Pulmonary Disease and the Cardiovascular System: Vascular Repair and Regeneration as a Therapeutic Target
JF  - Frontiers in Cardiovascular Medicine
N2  - Chronic obstructive pulmonary disease (COPD) is a major cause of morbidity and mortality worldwide and encompasses chronic bronchitis and emphysema. It has been shown that vascular wall remodeling and pulmonary hypertension (PH) can occur not only in patients with COPD but also in smokers with normal lung function, suggesting a causal role for vascular alterations in the development of emphysema. Mechanistically, abnormalities in the vasculature, such as inflammation, endothelial dysfunction, imbalances in cellular apoptosis/proliferation, and increased oxidative/nitrosative stress promote development of PH, cor pulmonale, and most probably pulmonary emphysema. Hypoxemia in the pulmonary chamber modulates the activation of key transcription factors and signaling cascades, which propagates inflammation and infiltration of neutrophils, resulting in vascular remodeling. Endothelial progenitor cells have angiogenesis capabilities, resulting in transdifferentiation of the smooth muscle cells via aberrant activation of several cytokines, growth factors, and chemokines. The vascular endothelium influences the balance between vaso-constriction and -dilation in the heart. Targeting key players affecting the vasculature might help in the development of new treatment strategies for both PH and COPD. The present review aims to summarize current knowledge about vascular alterations and production of reactive oxygen species in COPD. The present review emphasizes on the importance of the vasculature for the usually parenchyma-focused view of the pathobiology of COPD.
KW  - COPD
KW  - emphysema
KW  - pulmonary hypertension
KW  - hypoxia
KW  - oxidative stress
Y1  - 2021
U6  - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-235631
SN  - 2297-055X
VL  - 8
ER  -